Alzamend Neuro, Inc.

This early-stage study is testing a new, personalized cell therapy designed to train the body's immune system to fight Alzheimer's disease. Doctors take a patient's own immune cells, load them with a modified Alzheimer's-related protein, and inject them back to potentially trigge…

This early-stage study aims to understand how a new crystalized form of lithium, called AL001, compares to a standard lithium pill. Six healthy volunteers will take both forms for two weeks each while staying in a hospital research unit. Researchers will use blood tests and brain…